Addex Therapeutics Ltd. (ADXN)
3.18
+0.08
(+2.58%)
USD |
NASDAQ |
Oct 06, 16:00
2.97
-0.21
(-6.60%)
After-Hours: 20:00
Addex Therapeutics Profit Margin (Quarterly) : -17.52K% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -17.52K% |
| March 31, 2026 | -22.29K% |
| December 31, 2025 | -11.59K% |
| September 30, 2025 | -3.18K% |
| June 30, 2025 | -5.38K% |
| March 31, 2025 | -2.07K% |
| December 31, 2024 | -79.77K% |
| September 30, 2024 | -2.62K% |
| June 30, 2024 | -1.26K% |
| March 31, 2024 | -312.9% |
| December 31, 2023 | -583.4% |
| September 30, 2023 | -215.9% |
| June 30, 2023 | -82.51% |
| March 31, 2023 | -73.70% |
| December 31, 2022 | -609.8% |
| September 30, 2022 | -988.1% |
| Date | Value |
|---|---|
| June 30, 2022 | -3.87K% |
| March 31, 2022 | -2.39K% |
| December 31, 2021 | -1.10K% |
| September 30, 2021 | -524.7% |
| June 30, 2021 | -470.2% |
| March 31, 2021 | -310.8% |
| December 31, 2020 | -116.3% |
| September 30, 2020 | -10.15K% |
| June 30, 2020 | -359.5% |
| March 31, 2020 | -474.0% |
| December 31, 2007 | |
| June 30, 2007 | -7.35K% |
| March 31, 2007 | -4.45K% |
| December 31, 2006 | |
| June 30, 2006 | -391.4% |
| March 31, 2006 | -406.6% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Novartis AG | 22.61% |
| Roche Holding AG | -- |
| Oculis Holding AG | -- |
| Sandoz Group AG | -- |
| Galderma Group AG | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -149.3% |
| Return on Assets | -113.5% |
| Return on Invested Capital | -147.5% |
| Gross Profit Margin (Quarterly) | -153.2% |
| Operating Margin (Quarterly) | -6.48K% |
| Return on Net Operating Assets | -2.66K% |